W 15 (Pioglitazone hydrochloride 15 mg (base))
Pill imprint W 15 has been identified as Pioglitazone hydrochloride 15 mg (base).
Pioglitazone is used in the treatment of nonalcoholic fatty liver disease; diabetes, type 2 and belongs to the drug class thiazolidinediones. Risk cannot be ruled out during pregnancy. Pioglitazone 15 mg (base) is not a controlled substance under the Controlled Substance Act (CSA).
- W 15
- 15 mg (base)
- Prescription only
- Drug Class:
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Watson Laboratories, Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- carboxymethylcellulose calcium
hydroxypropyl cellulose (type l)
|NDC Code||Manufacturer / Repackager|
|68084-0878||Amerisource Health Services|
Note: Inactive ingredients may vary.
More about pioglitazone
- Other brands: Actos
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.